Skip to content
hcg-service-hero-1

Insights From Halloran

Rania JalalJun 13, 2025 8:03:57 AM5 min read

The Post-Approval Odyssey: Navigating CMC Changes After Product Launch

Start Reading
Gail WinslowJun 9, 2025 12:44:39 PM1 min read

Halloran Consulting Group Announces Leadership Promotions

[Boston, MA June 9] — Halloran Consulting Group, a ProductLife Group (PLG) company, is ...
Start Reading
Josh WootenJun 6, 2025 1:28:05 PM5 min read

Developing Drugs and Biologics for Weight Reduction – Examining FDA’s New Guidance

Start Reading
Josh WootenMay 29, 2025 11:21:46 AM1 min read

When Is the Best Time for a Pre-IND Meeting?

Start Reading
Halloran Consulting GroupMay 27, 2025 10:43:30 AM< 1 min read

Comprehensive Organizational Assessment for Large MedTech Company Focused on Future-State People, Process, and Systems Needs

Comprehensive Organizational Assessment for Large MedTech Company Focused on Future-State ...
Start Reading
Shawn Roach, PhD, RACMay 23, 2025 9:19:54 AM< 1 min read

Strategic Insights for Biopharma Teams Navigating the IND Process

Contributing author: Carolina Ahrendt, MBA, PMP
Start Reading
Carolina Ahrendt, MBA, PMPMay 22, 2025 9:45:53 AM1 min read

Mastering Program Management and Leadership: Five Pillars to Drug Development Excellence Webinar

Join our webinar to clarify the roles of Program Leaders (PL) and Program Managers (PM) ...
Start Reading
Shawn Roach, PhD, RACMay 16, 2025 11:18:11 AM2 min read

Halloran’s Regulatory Lens – What We’re Watching in 2025

Start Reading
Monika Swietlicka, MBA, BFA, BScMay 14, 2025 12:29:31 PM2 min read

Platform Promise vs Regulatory Reality: Navigating Product-Specific Expectations in Cell and Gene Therapy

Start Reading
Josh WootenMay 8, 2025 7:57:17 AM1 min read

Start it off Right: The Importance of Building an IND from High-Quality Nonclinical Reports

Nonclinical reports are one of the most critical pieces for building an IND, but are ...
Start Reading